Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
2129.HK Stock Summary
In the News
2129.HK Financial details
Company Rating
Buy
Market Cap
146.25M
Income
-
Revenue
-
Book val./share
0.04
Cash/share
0.02
Dividend
-
Dividend %
-
Employees
221
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
0.34
P/B
-
P/C
5.65
P/FCF
4.71
Quick Ratio
2.11
Current Ratio
3.6
Debt / Equity
0.31
LT Debt / Equity
0.18
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
56.52%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
4.42%
Revenue last 5Y
7%
Revenue Q/Q
9.12%
EPS Q/Q
80%
-
-
-
-
SMA20
-
SMA50
22.22%
SMA100
10%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
11%
ROC
0.11%
Gross Margin
32%
Oper. Margin
10%
Profit Margin
8%
Payout
-
Shs Outstand
1.25B
Shs Float
312.5M
-
-
-
-
Target Price
-
52W Range
0.086-0.14
52W High
-
52W Low
-
RSI
52.06
Rel Volume
0.97
Avg Volume
273.98K
Volume
265K
Perf Week
3.67%
Perf Month
7.62%
Perf Quarter
7.62%
Perf Half Y
-1.74%
-
-
-
-
Beta
0.552
-
-
Volatility
0%, 0%
Prev Close
-8.13%
Price
0.113
Change
-5.04%
2129.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.03 | 0.03 | 0.03 | 0.04 | 0.05 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0.01 | 0.01 | 0.01 | 0 | 0.01 | |
Free cash flow per share | 0 | 0.01 | 0.01 | 0 | 0 | |
Cash per share | 0 | 0.01 | 0.01 | 0.02 | 0.02 | |
Book value per share | 0.02 | 0.02 | 0.02 | 0.03 | 0.04 | |
Tangible book value per share | 0.01 | 0.02 | 0.02 | 0.03 | 0.04 | |
Share holders equity per share | 0.02 | 0.02 | 0.02 | 0.03 | 0.04 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0.01 | |
Market cap | 76.22M | 75.5M | 74.55M | 27.57M | 26.21M | |
Enterprise value | 73.44M | 70.38M | 67.47M | 7.63M | 26.36M | |
P/E ratio | 21.08 | 12.45 | 17.51 | 9.65 | 5.74 | |
Price to sales ratio | 1.87 | 1.73 | 1.85 | 0.6 | 0.46 | |
POCF ratio | 10.65 | 9.98 | 8.95 | 5.4 | 3.94 | |
PFCF ratio | 14.54 | 10.5 | 9.12 | 6.19 | 6.44 | |
P/B Ratio | 4.06 | 3.04 | 2.97 | 0.68 | 0.58 | |
PTB ratio | 4.06 | 3.04 | 2.97 | 0.68 | 0.58 | |
EV to sales | 1.81 | 1.61 | 1.67 | 0.17 | 0.46 | |
Enterprise value over EBITDA | 12.67 | 7.35 | 7.86 | 0.97 | 2.48 | |
EV to operating cash flow | 10.26 | 9.3 | 8.1 | 1.49 | 3.97 | |
EV to free cash flow | 14.01 | 9.79 | 8.25 | 1.71 | 6.48 | |
Earnings yield | 0.05 | 0.08 | 0.06 | 0.1 | 0.17 | |
Free cash flow yield | 0.07 | 0.1 | 0.11 | 0.16 | 0.16 | |
Debt to equity | 0.09 | 0.24 | 0.23 | 0.1 | 0.23 | |
Debt to assets | 0.06 | 0.17 | 0.15 | 0.08 | 0.16 | |
Net debt to EBITDA | -0.48 | -0.53 | -0.82 | -2.55 | 0.01 | |
Current ratio | 2.89 | 3.43 | 3.03 | 4.6 | 3.6 | |
Interest coverage | 108.42 | 54.79 | 22.01 | 16.59 | 33.7 | |
Income quality | 1.53 | 1 | 1.59 | 1.37 | 1.2 | |
Dividend Yield | 0.06 | 0 | 0.05 | 0 | 0 | |
Payout ratio | 1.3 | 0 | 0.94 | 0 | 0 | |
Sales general and administrative to revenue | 0.1 | 0.06 | 0.24 | 0.23 | 0.23 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0.04 | |
Capex to operating cash flow | -0.27 | -0.05 | -0.02 | -0.13 | -0.39 | |
Capex to revenue | -0.05 | -0.01 | 0 | -0.01 | -0.05 | |
Capex to depreciation | -1.55 | -0.2 | -0.05 | -0.16 | -0.52 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.03 | 0.05 | 0.04 | 0.04 | 0.05 | |
ROIC | 0.17 | 0.17 | 0.12 | 0.06 | 0.07 | |
Return on tangible assets | 0.14 | 0.17 | 0.11 | 0.06 | 0.07 | |
Graham Net | 0 | 0 | 0 | 0.01 | 0 | |
Working capital | 10.11M | 16.39M | 16.83M | 28.97M | 30.36M | |
Tangible asset value | 18.65M | 24.65M | 24.95M | 40.59M | 43.85M | |
Net current asset value | 8.51M | 11.46M | 12.37M | 26.69M | 23.22M | |
Invested capital | 0.09 | 0.24 | 0.23 | 0.1 | 0.23 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 1.16M | 1.22M | 1.07M | 1.55M | 2.23M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 18.77 | 14.87 | 14.59 | 23 | 22.76 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 19.45 | 24.54 | 25.02 | 15.87 | 16.04 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.19 | 0.24 | 0.17 | 0.07 | 0.1 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0.14 | 0.15 | |
Net income per share | 0 | 0 | 0 | 0.01 | 0.01 | |
Operating cash flow per share | 0 | 0 | 0 | 0.01 | 0.04 | |
Free cash flow per share | 0 | 0 | 0 | 0.01 | -0.01 | |
Cash per share | 0 | 0 | 0 | 0.02 | 0.02 | |
Book value per share | 0 | 0 | 0 | 0.04 | 0.04 | |
Tangible book value per share | 0 | 0 | 0 | 0.04 | 0.04 | |
Share holders equity per share | 0 | 0 | 0 | 0.04 | 0.04 | |
Interest debt per share | 0 | 0 | 0 | 0.01 | 0.01 | |
Market cap | 0 | 0 | 0 | 26.21M | 20.98M | |
Enterprise value | -17.43M | -19.94M | -24.19M | 26.36M | 7.4M | |
P/E ratio | 0 | 0 | 0 | 0.65 | 0.29 | |
Price to sales ratio | 0 | 0 | 0 | 0.15 | 0.11 | |
POCF ratio | 0 | 0 | 0 | 1.51 | 0.47 | |
PFCF ratio | 0 | 0 | 0 | 2.77 | -1.77 | |
P/B Ratio | 0 | 0 | 0 | 0.58 | 0.43 | |
PTB ratio | 0 | 0 | 0 | 0.58 | 0.43 | |
EV to sales | 0 | 0 | 0 | 0.15 | 0.04 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0.99 | 0.16 | |
EV to operating cash flow | 0 | 0 | 0 | 1.51 | 0.17 | |
EV to free cash flow | 0 | 0 | 0 | 2.79 | -0.62 | |
Earnings yield | 0 | 0 | 0 | 0.38 | 0.86 | |
Free cash flow yield | 0 | 0 | 0 | 0.36 | -0.57 | |
Debt to equity | 0.13 | 0.1 | 0.06 | 0.23 | 0.31 | |
Debt to assets | 0.1 | 0.08 | 0.05 | 0.16 | 0.21 | |
Net debt to EBITDA | 0 | 0 | 0 | 0.01 | -0.3 | |
Current ratio | 4.97 | 4.6 | 5.36 | 3.6 | 4.17 | |
Interest coverage | 0 | 0 | 0 | 23.47 | 9.94 | |
Income quality | 0 | 0 | 0 | 1.73 | 2.48 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0.04 | 0.03 | |
Capex to operating cash flow | 0 | 0 | 0 | -0.46 | -1.27 | |
Capex to revenue | 0 | 0 | 0 | -0.05 | -0.3 | |
Capex to depreciation | 0 | 0 | 0 | -0.56 | -2.3 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0.08 | 0.11 | |
ROIC | 0 | 0 | 0 | 0.15 | 0.23 | |
Return on tangible assets | 0 | 0 | 0 | 0.16 | 0.27 | |
Graham Net | 0 | 0 | 0 | 0 | 0.01 | |
Working capital | 29.83M | 28.97M | 33.65M | 30.36M | 31.81M | |
Tangible asset value | 38.86M | 40.59M | 43.36M | 43.85M | 46.95M | |
Net current asset value | 26.21M | 26.69M | 32.54M | 23.22M | 21.39M | |
Invested capital | 0.13 | 0.1 | 0.06 | 0.23 | 0.31 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 1.92 | 2.19 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 46.91 | 41.08 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0.22 | 0.37 | |
Capex per share | 0 | 0 | 0 | -0.01 | -0.05 |
2129.HK Frequently Asked Questions
What is Legion Consortium Limited stock symbol ?
Legion Consortium Limited is a SG stock and trading under the symbol 2129.HK
What is Legion Consortium Limited stock quote today ?
Legion Consortium Limited stock price is $0.113 today.
Is Legion Consortium Limited stock public?
Yes, Legion Consortium Limited is a publicly traded company.